Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study

Renee Heffron(University of Washington), David N. Fredricks(University of Washington), Jairam R. Lingappa(University of Namur), Allan Ronald(University of Namur), Craig R. Cohen(University of California, San Francisco), James Kiarie(World Health Organization), Jonathan Wangisi(The AIDS Support Organization), Carey Farquhar(University of Washington), Elizabeth A. Bukusi(University of California, San Francisco), Elly Katabira(University of Namur), Lisa M. Frenkel(Infectious Disease Research Institute), Jennifer E. Balkus(Infectious Disease Research Institute), Matthew M Munch(Fred Hutch Cancer Center), Nelly Mugo(University of Washington), Grace John‐Stewart(Washington State Department of Health), Craig W. Hendrix(Unknown), Robert W. Coombs(University of Namur), Patrick Ndase, Jared M. Baeten(University of Washington), Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Edwin Were(University of Namur), Jordan W. Tappero, M. Juliana McElrath(Fred Hutch Cancer Center), Tina L. Fiedler(Fred Hutch Cancer Center), Connie Celum(University of Washington), Elioda Tumwesigye, R. Scott McClelland(University of Washington), James D. Campbell(Centers for Disease Control and Prevention), Kenneth H. Fife(Indiana University – Purdue University Indianapolis)
The Lancet HIV
July 19, 2017
Cited by 51


Related Papers